Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Erlinge

Showing results (411-420 of 490) with videos related to

Pageof 49
Sort By:
International Journal of Cardiology|December 8, 2022
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney functionJosefin Mörtberg, Barbara Salzinger, Kristina Lundwall, et al.
Resuscitation|December 21, 2016
Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperaturesJosef Dankiewicz, Niklas Nielsen, Adam Linder, et al.
Critical Care (London, England)|June 21, 2017
Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °CPascal Stammet, Josef Dankiewicz, Niklas Nielsen, et al.
The American Journal of Cardiology|September 12, 2016
Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict OutcomeMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
Plos One|June 11, 2025
Associations between physical activity and CVD-related metabolomic and proteomic biomarkersÖrjan Ekblom, Harry Björkbacka, Mats Börjesson, et al.
Plos One|January 19, 2017
Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial SubstudySebastian Wiberg, Christian Hassager, Pascal Stammet, et al.
Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.
Coronary Artery Disease|April 4, 2026
Intra-aortic balloon support for myocardial infarction with cardiogenic shock: insights from the Swedish Coronary Angiography and Angioplasty RegistrySebastian Völz, Pétur Pétursson, Björn Redfors, et al.
American Heart Journal|June 20, 2017
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trialOle Fröbert, Matthias Götberg, Oskar Angerås, et al.
Journal of Cardiac Failure|April 18, 2023
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial ResultsCarolyn S P Lam, Lars H Lund, Sanjiv J Shah, et al.
Pageof 49

Showing results (411-420 of 490) with videos related to

Sort By:
Pageof 49
International Journal of Cardiology|December 8, 2022
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney functionJosefin Mörtberg, Barbara Salzinger, Kristina Lundwall, et al.
Resuscitation|December 21, 2016
Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperaturesJosef Dankiewicz, Niklas Nielsen, Adam Linder, et al.
Critical Care (London, England)|June 21, 2017
Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °CPascal Stammet, Josef Dankiewicz, Niklas Nielsen, et al.
The American Journal of Cardiology|September 12, 2016
Usefulness of Serum B-Type Natriuretic Peptide Levels in Comatose Patients Resuscitated from Out-of-Hospital Cardiac Arrest to Predict OutcomeMartin Frydland, Jesper Kjaergaard, David Erlinge, et al.
Plos One|June 11, 2025
Associations between physical activity and CVD-related metabolomic and proteomic biomarkersÖrjan Ekblom, Harry Björkbacka, Mats Börjesson, et al.
Plos One|January 19, 2017
Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial SubstudySebastian Wiberg, Christian Hassager, Pascal Stammet, et al.
Journal of the American Heart Association|July 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI TrialRobert F Storey, John Deanfield, Stefan James, et al.
Coronary Artery Disease|April 4, 2026
Intra-aortic balloon support for myocardial infarction with cardiogenic shock: insights from the Swedish Coronary Angiography and Angioplasty RegistrySebastian Völz, Pétur Pétursson, Björn Redfors, et al.
American Heart Journal|June 20, 2017
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trialOle Fröbert, Matthias Götberg, Oskar Angerås, et al.
Journal of Cardiac Failure|April 18, 2023
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial ResultsCarolyn S P Lam, Lars H Lund, Sanjiv J Shah, et al.
Pageof 49